Common Contracts
6 similar Executive Employment Agreement contracts by Keros Therapeutics, Inc.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 31st, 2022 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Christopher Rovaldi (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of February 1, 2022 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 2nd, 2021 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Simon Cooper (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of August 2, 2021 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Keith Regnante (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Jennifer Lachey (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Claudia Ordonez (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Jasbir Seehra (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
